The Rapidly Evolving Epstein-Barr Virus Diagnostics Market is...

The Rapidly Evolving Epstein-Barr Virus Diagnostics Market is driven by Growing Prevalence of Associated Diseases

Posté 2025-03-04 07:33:43

Epstein-Barr Virus (EBV) is a herpes virus that infects B cells and epithelial cells of the host. EBV infection causes infectious mononucleosis and is associated with several cancers such as Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma, and gastric carcinoma. Diagnosis of EBV infection involves serological and molecular detection methods.

The Epstein-Barr Virus (EBV) market is estimated to be valued at USD 1.4 Billion in 2024 and is expected to reach USD 2.1 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.53% from 2024 to 2031.

The growing prevalence of EBV-associated cancers and mononucleosis is a major factor driving the demand for Epstein-Barr Virus (EBV) Market. According to the National Cancer Institute, approximately 1.5 million cases of cancer worldwide are associated with EBV each year

Get More Insights On- Epstein-Barr Virus (EBV) Market

Get this Report in Japanese Language: エプスタイン・バーウイルス（EBV）市場

Get this Report in Korean Language: 엡스타인-바 바이러스(EBV) 시장

Explore More Related Articles- Modern Beach Houses - Embodying Luxury and Style by the Sea